Methods and compositions for treating depression using optically pure fluoxetine
Patent 5104899 Issued on April 14, 1992. Estimated Expiration Date: August 13, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
A method and composition are disclosed utilizing the pure S(+) isomer of fluoxetine, which is a potent antidepressant substantially free of adverse toxic or psychological effects, having a rapid onset of action and a high response rate.
Other References
Wong et al., Acta Pharm. Nord. 2(3): 171-180 (1990)
Caccia et al., Psychopharmacology 100: 509-514 (1990)
Benfield et al., Drugs 32: 481-508 (1986)
Coutts, et al., Chirality, 1: 99-120 (1989)
Coutts, et al., Prog. Neuro-Psychopharmacol, and Biol. Psychiat., 13: 405-417 (1989)
Robertson, et al., J. Med. Chem., 31: 1412-1417 (1988)
Corey et al., Tetrahedron Lett., 30:(39) 5207-5210 (1989)
Teicher, et al., Am. J. Psychiatry, 147(2): 207-210 )1990)
Scip's New Product Review, No. 7: 13-14 (1986)
Gao, et al., J. Org. Chem., 53(17): 4081-4084 (1988)
Bremmer, J. Clin. Psychiatry, 45(10): 414-420 (1984)
Wong, et al., Pharmacology, Biochemistry and Behavior, 31: 475-479 (1988)
Fuller, et al., Pharmacology, Biochemistry and Behavior, 24: 281-284 (1986)
Wong, et al., Drug Development Research, 6: 397-403 (1985)
Kim et al., Physiology & Behavior, vol. 42: 319-322 (1988)
August 13, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
